肝胰胆手术后门静脉闭塞相关延迟性空肠静脉曲张出血的门静脉支架置入治疗
本研究回顾了11例肝胰胆手术后门静脉闭塞伴延迟性(≥3个月)空肠静脉曲张出血行门静脉支架置入的患者,技术成功率90.9%、治疗有效率100%、临床成功率81.8%,平均随访9个月支架一期通畅率88.9%,无操作相关并发症或死亡,作者认为介入门静脉支架置入是有效治疗方法。
要点
- 肝胰胆手术后门静脉闭塞可导致空肠静脉曲张出血,门静脉支架置入技术成功率90.9%、治疗有效率100%。
- 临床成功率81.8%,平均随访9个月支架一期通畅率88.9%,无操作相关并发症或死亡。
- 对术后门静脉闭塞伴延迟性空肠静脉曲张出血,作者认为介入门静脉支架置入是有效治疗方法。
核心结论
- 介入门静脉支架置入是肝胰胆手术后门静脉闭塞所致延迟性空肠静脉曲张出血的有效治疗方法。
研究设计与样本
- 回顾性研究,纳入2009年4月至2015年12月连续11例(年龄2-79岁,男8例、女3例)因术后门静脉闭塞伴延迟性(≥3个月)空肠静脉曲张出血行门静脉支架置入的患者,分析技术成功、治疗有效率(随访CT上空肠静脉曲张消失)和临床成功率,用Kaplan-Meier法绘制支架一期通畅率。
关键影像表现/征象
- 所有患者均行肝胰胆肿瘤手术,其中两名儿童因胆道闭锁行肝移植。
- 门静脉闭塞由术后良性改变(n=6)和局部肿瘤复发(n=5)引起。
- 静脉曲张出血发生于术后平均27个月(4至72个月),门静脉支架置入于术后平均37个月(4至121个月)进行。
诊断标准与关键数值
- 技术成功率、治疗有效率(随访CT空肠静脉曲张消失)、临床成功率分别为90.9%、100%、81.8%。
- 平均随访9个月期间门静脉支架一期通畅率为88.9%。
临床应用与阅片要点
- 对于肝胰胆手术后门静脉闭塞伴延迟性空肠静脉曲张出血,作者认为介入门静脉支架置入是有效治疗方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The study aimed to describe portal stenting for postoperative portal occlusion with delayed (≥ 3 months) variceal bleeding in the afferent jejunal loop.
MATERIALS AND METHODS: Eleven consecutive patients (age range, 2-79 years; eight men and three women) who underwent portal stenting between April 2009 and December 2015 were included in the study. Preoperative medical history and the postoperative clinical course were reviewed. Characteristics of portal occlusion and details of procedures were also investigated. Technical success, treatment efficacy (defined as disappearance of jejunal varix on follow-up CT), and clinical success were analyzed. Primary stent patency rate was plotted using the Kaplan-Meier method.
RESULTS: All patients underwent hepatobiliary-pancreatic cancer surgery except two children with liver transplantation for biliary atresia. Portal occlusion was caused by benign postoperative change (n = 6) and local tumor recurrence (n = 5). Variceal bleeding occurred at 27 months (4 to 72 months) and portal stenting was performed at 37 months (4 to 121 months), on average, postoperatively. Technical success, treatment efficacy, and clinical success rates were 90.9, 100, and 81.8%, respectively. The primary patency rate of portal stent was 88.9% during the mean follow-up period of 9 months. Neither procedure-related complication nor mortality occurred.
CONCLUSION: Interventional portal stenting is an effective treatment for delayed jejunal variceal bleeding due to portal occlusion after hepatobiliary-pancreatic surgery.
引用
- Hyun D, Park KB, Cho SK, et al. Portal Vein Stenting for Delayed Jejunal Varix Bleeding Associated with Portal Venous Occlusion after Hepatobiliary and Pancreatic Surgery. Korean J Radiol. 2017. PMID: 28860900. doi:10.3348/kjr.2017.18.5.828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。